Navigation Links
Watson to Present at Barclay's 2010 Global Healthcare Conference
Date:3/16/2010

MORRISTOWN, N.J., March 16 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that Paul Bisaro, Watson's president and chief executive officer, will provide an overview and update of the Company's business at the Barclay's 2010 Global Healthcare Conference on Tuesday, March 23, 2010 at 11:15 am Eastern Daylight Savings Time at the Loews Miami Beach Hotel.

This presentation will be webcast live and can be accessed on Watson Pharmaceuticals' Investor Relations Website at http://ir.watson.com.  The webcast can also be accessed at the following URL: http://cc.talkpoint.com/barc002/032310a_rb/?entity=27_LVKDFIY

An archived version will be available for 30 days after the live presentation and can be accessed at the same locations.

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc. is a global leader in the development and distribution of pharmaceuticals with a broad portfolio of generic products and a specialized portfolio of brand pharmaceuticals focused on urology and women's health. Watson has operations in many of the world's established and growing international markets.

For press releases and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.

(Logo:  http://www.newscom.com/cgi-bin/prnh/20100121/LA41294LOGO)

SOURCE Watson Pharmaceuticals, Inc.

Back to top

RELATED LINKS
http://www.watson.com

'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Watson Launches Generic Biaxin(R) XL
2. Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
3. Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia
4. Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
5. Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)
6. Watson and Barr Settle Lawsuit Over Oxytrol(R)
7. Watson to Host Conference Call and Webcast to Discuss Fourth Quarter 2009 Earnings and 2010 Outlook
8. Watson Completes Acquisition of Eden Biodesign
9. Watson to Present at Credit Suisse Healthcare Conference
10. Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy
11. Watson Files FDA Application for Generic Rozerem(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... , 22. März 2017   ... und weltweit tätige Anbieter von Produkten und ... den Erwerb von EPL Archives Inc. bekannt, ... der Kunden im kompletten Zyklus regulierter Forschung, ... von Proben, Speicherung von Dokumenten und Zusatzdienstleistungen ...
(Date:3/22/2017)... , March 22, 2017  Ablation is ... for a wide range of purposes, from cancerous ... abnormally conducting cardiac tissue in atrial fibrillation and ... is pushing the researchers to innovate and improvise ... The ablation device global market is expected ...
(Date:3/22/2017)... 22, 2017 TapImmune, Inc. ... the development of innovative peptide and gene-based immunotherapeutics ... today announced that it will participate in two ... Glynn Wilson , Chairman and CEO of ... business, clinical pipeline and partnering opportunities for its ...
Breaking Medicine Technology:
(Date:3/22/2017)... ... 22, 2017 , ... Chris Humphrey Insurance Agency, a North Carolina firm offering ... coastal plains region, is initiating a charity event to raise support for five year ... with leukemia on a Friday evening in September 2014. At the time, Dillyn was ...
(Date:3/22/2017)... ... March 22, 2017 , ... The Senior Citizens ... and prevent a default on the federal debt — including the debt held by ... growing concern, ” said TSCL in a letter to House and Senate budget leaders. ...
(Date:3/22/2017)... ... March 22, 2017 , ... NYC Chiropractor Dr. Steven Shoshany recently helped host ... its kind in the U.S. and focused on a new protocol for treating pain. ... to New York, and furthermore the first seminar in the country was hosted ...
(Date:3/22/2017)... ... 22, 2017 , ... The National Association for Business Resources (NABR) ... and Brightest in Wellness® companies for 2017. , American Specialty Health (ASH) ... in wellness for its employees. ASH is one of only nine other San Diego ...
(Date:3/20/2017)... ... 2017 , ... New research conducted by The Beryl Institute ... findings initially announced and live streamed at Patient Experience Conference 2017 , ... the challenges and opportunities they are facing and the steps they are taking ...
Breaking Medicine News(10 mins):